What are the diagnostic criteria and recommended management for hypertension in children?

High Blood Pressure in Children: Diagnostic Criteria and Management

Screen children annually for hypertension starting at age 3 years (or at every visit if risk factors like obesity, diabetes, heart disease, or kidney disease are present), using auscultation as the preferred measurement method, and confirm the diagnosis with ambulatory blood pressure monitoring (ABPM) before initiating extensive workup or treatment. 1

Diagnostic Criteria

Blood Pressure Classification

The 2017 American Academy of Pediatrics guidelines establish clear thresholds that differ by age group 1:

For children <13 years old:

• Normal BP: <90th percentile for age, sex, and height 1
• Elevated BP: ≥90th to <95th percentile for age, sex, and height 1
• Stage 1 Hypertension: ≥95th percentile for age, sex, and height 1
• Stage 2 Hypertension: ≥95th percentile + 12 mm Hg 1

For adolescents ≥13 years old (aligned with adult criteria):

• Normal BP: <120/<80 mm Hg 1
• Elevated BP: 120-129/<80 mm Hg 1
• Stage 1 Hypertension: 130-139/80-89 mm Hg 1
• Stage 2 Hypertension: ≥140/90 mm Hg 1

Confirming the Diagnosis

Hypertension requires elevated BP at 3 separate clinical encounters unless the patient is symptomatic. 1

ABPM is strongly recommended to confirm hypertension because white-coat hypertension is highly prevalent in children, making ABPM cost-effective by preventing unnecessary workups. 1 Home BP monitoring lacks sufficient pediatric evidence and should not be used for diagnosis. 1

Additional ABPM Indications

Beyond diagnosis confirmation, use ABPM for 1:

• Suspected white-coat hypertension 1
• Masked hypertension evaluation in children with repaired coarctation of the aorta 1
• BP pattern assessment in high-risk conditions (chronic kidney disease, obstructive sleep apnea) 1
• Monitoring treatment effectiveness 1
• Evaluation of heart and kidney transplant recipients 1

Clinical Evaluation

History Components

Obtain the following specific historical elements 1:

• Perinatal history: Birth weight, gestational age, maternal hypertension 1
• Nutritional history: Sodium intake, dietary patterns 1
• Physical activity patterns: Frequency, duration, intensity of exercise 1
• Psychosocial factors: Environmental stress, sleep patterns 1, 2
• Family history: Hypertension, cardiovascular disease, kidney disease 1

Screening for Secondary Causes

Primary hypertension is now the most common cause in children, especially adolescents, with obesity and suboptimal lifestyle as leading risk factors. 2, 3 However, evaluate for secondary causes, particularly in younger children or those with severe hypertension. 1

Specific diagnostic tests:

• Doppler renal ultrasonography may screen for renovascular disease in normal-weight children ≥8 years who can cooperate with the procedure 1
• CTA or MRA (not nuclear renography) for suspected renal artery stenosis 1
• Routine microalbuminuria testing is NOT recommended for primary hypertension 1

Target Organ Damage Assessment

Echocardiography should be performed when considering pharmacologic treatment to assess for left ventricular hypertrophy (LVH), which is the most common target organ damage in hypertensive children. 1, 2

LVH definitions: 1

• Children >8 years: LV mass >51 g/m^2.7 (both sexes) 1
• Alternative criteria: LV mass >115 g/BSA (boys) or >95 g/BSA (girls) 1

Do NOT perform routine electrocardiography for LVH screening—it lacks sensitivity in children. 1

Repeat echocardiography at 6-12 month intervals if persistent hypertension despite treatment, concentric LVH, or reduced LV ejection fraction exists. 1 For stage 2 hypertension, secondary hypertension, or inadequately treated stage 1 hypertension without initial LVH, consider yearly echocardiography. 1

Management Strategy

Treatment Goals

Target BP should be <90th percentile in children <13 years and <130/80 mm Hg in adolescents ≥13 years. 1

Lifestyle Modifications (First-Line for All)

At diagnosis, immediately advise: 1

• DASH diet implementation 1
• Moderate to vigorous physical activity 3-5 days per week, 30-60 minutes per session 1
• Weight loss if overweight or obese 3

Pharmacologic Therapy Indications

Initiate antihypertensive medications when: 1, 3

• Symptomatic hypertension (headaches, cognitive changes) 1, 3
• Stage 2 hypertension without clearly modifiable factors (e.g., obesity) 1, 3
• LVH detected on echocardiography 1, 3
• Persistent hypertension despite lifestyle modifications 1, 3
• Any stage hypertension with chronic kidney disease or diabetes 3

Medication Selection

First-line agents (all equally effective, safe, and well-tolerated): 1, 3

• ACE inhibitors 1, 3
• Angiotensin receptor blockers (ARBs) 1, 3
• Long-acting calcium channel blockers 1, 3
• Thiazide diuretics 1, 3

Special Populations

Children with CKD: 1

• Evaluate BP at every medical encounter 1
• Target 24-hour mean arterial pressure <50th percentile by ABPM 1
• Screen yearly with ABPM for masked hypertension even if office BP appears controlled 1
• Screen for proteinuria 1
• Use ACE inhibitor or ARB if proteinuria present 1

Children with diabetes (Type 1 or Type 2):

• Evaluate BP at every medical encounter 1
• Treat if BP ≥95th percentile 1

Common Pitfalls

Avoid these errors:

• Relying solely on office BP measurements without ABPM confirmation—this leads to overdiagnosis due to white-coat hypertension 1
• Using home BP monitoring for diagnosis—insufficient pediatric validation 1
• Performing routine ECG for LVH screening—poor sensitivity in children 1
• Ordering microalbuminuria testing in primary hypertension—not recommended 1
• Delaying lifestyle modifications—these should begin immediately at diagnosis 1
• Failing to screen high-risk children (obesity, diabetes, kidney disease) at every visit 1